-
Product Insights
NewDry Powder Inhaler Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder. GlobalData's Medical Devices sector report, “Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Dry Powder Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Dry Powder Inhaler Devices report...
-
Sector Analysis
NewAttention Deficit Hyperactivity Disorder (ADHD) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Attention Deficit Hyperactivity Disorder (ADHD) Market Report Overview The ADHD market across the 7MM was valued at $11.9 billion in 2022. The market will decline at a CAGR of less than 1% from 2022 to 2032. The 7MM includes the US, France, Germany, Italy, Spain, the UK, and Japan. Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with specific criteria for children and adults. ADHD is characterized by age-inappropriate, extreme, and impairing levels of inattention and/or hyperactivity and impulsivity. It is...
-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Product Insights
Arthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Arthralgia Clinical Trial Report Overview A total of 713 Arthralgia clinical trials were conducted as of March 2024. The Arthralgia clinical trial report provides a comprehensive understanding of the Arthralgia clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·       North America ·       Europe ·       Asia-Pacific ·       ...
-
Product Insights
Obsessive-Compulsive Disorder Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Obsessive-Compulsive Disorder Clinical Trial Market Report Overview Obsessive-compulsive disorder clinical trial market research report provides top line data relating to the clinical trials on obsessive-compulsive disorder. The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials. The...
-
Product Insights
Ankylosing Spondylitis (Bekhterev’s Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Ankylosing Spondylitis Clinical Trial Analysis Report Overview A total of 1,072 Ankylosing Spondylitis clinical trials were conducted as of January 2024. The Ankylosing Spondylitis clinical trial report provides a comprehensive understanding of the Ankylosing Spondylitis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       ...
-
Product Insights
NewPolyarticular Juvenile Idiopathic Arthritis (PJIA) – Drugs In Development, 2024
Empower your strategies with our Polyarticular Juvenile Idiopathic Arthritis (PJIA) – Drugs In Development, 2024 report and make more profitable business decisions. Polyarticular juvenile idiopathic arthritis (PJIA) affects five or more joints. PJIA causes inflammation in the small joints of the fingers and hands, but weight-bearing joints and the jaw can also be affected. Symptoms include fevers, pink rash, eye inflammation, joint pain, joint swelling, and problems with bone development and growth. Treatment includes painkillers, non-steroidal anti-inflammatory drugs (NSAIDs), and disease-modifying...
-
Product Insights
NewPsoriatic Arthritis – Drugs In Development, 2024
Empower your strategies with our Psoriatic Arthritis – Drugs In Development, 2024 report and make more profitable business decisions. Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis. Symptoms include swollen fingers and toes, foot pain, and lower back pain. Risk factors include age, family history, and psoriasis. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs), immunosuppressants, and surgery. The Psoriatic Arthritis drugs in development market research report provide comprehensive information on the therapeutics under development for Psoriatic...
-
Product Insights
NewPost Menopausal Osteoporosis – Drugs In Development, 2024
Empower your strategies with our Post Menopausal Osteoporosis – Drugs In Development, 2024 report and make more profitable business decisions. Postmenopausal osteoporosis is the most common form of osteoporosis. It affects many women after menopause. Symptoms include back pain, loss of height, or spinal deformities such as stooped posture. Risk factors include age, gender, family history, bone structure, and body weight. Treatment includes hormone replacement therapy (HRT) and vitamin D analogues. The Post Menopausal Osteoporosis drugs in development market research report...
-
Product Insights
NewHidradenitis Suppurativa – Drugs In Development, 2024
Empower your strategies with our Hidradenitis Suppurativa – Drugs In Development, 2024 report and make more profitable business decisions. Hidradenitis suppurativa (HS) is a chronic skin condition that features pea- to marble-sized lumps under the skin. Also known as acne inversa, these deep-seated lumps typically develop in areas where skin rubs together, such as the armpits, groin, between the buttocks, and under the breasts. The Hidradenitis Suppurativa drugs in development market research report provide comprehensive information on the therapeutics under development...